Header Logo

Connection

CHRISTIE BALLANTYNE to Rivaroxaban

Back to Details
This is a "connection" page, showing publications CHRISTIE BALLANTYNE has written about Rivaroxaban.
CHRISTIE BALLANTYNE
Connection Strength
0.171
Rivaroxaban
  1. Eligibility for Low-Dose Rivaroxaban Based on the COMPASS Trial: Insights from the Veterans Affairs Healthcare System. Cardiovasc Drugs Ther. 2021 06; 35(3):533-538.
    View in: PubMed
    Score: 0.171
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.